AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Orthocell Sets Sixth Consecutive Quarterly Revenue Record, US Rollout Accelerates
ByAinvest
Thursday, Oct 9, 2025 7:23 pm ET1min read
Orthocell Ltd reported a record quarterly revenue of A$3 million for Q3 2025, up 11% from the previous quarter and marking a sixth consecutive record. The growth was driven by Remplir's expansion in Australia and Singapore. The company expects material revenue from US Remplir sales to build during Q4 2025 and into H2 2026. Orthocell has established a distributor network across 25 US states and is progressing state licenses.
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has announced its intention to release its financial results for the third quarter 2025 before the Nasdaq market opens on November 5, 2025. The company expects revenue for the quarter to be in the range of $92.5 million to $93.0 million, with a non-GAAP gross margin of 77% to 79%. For the full year 2025, InMode reiterates its guidance of $365 million to $375 million in revenue, consistent with its prior projections [1].The company will host a conference call to discuss the third quarter 2025 financial results on November 5, 2025, at 8:30 a.m. Eastern Time. Speakers will include Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer, and Dr. Michael Kreindel, Chief Technology Officer. Interested parties can pre-register for the call using the link provided in the press release [1].
InMode's financial results will be available on its website and through a replay of the conference call, which will be available for 90 days. The company encourages investors to review the full report and conference call for a comprehensive understanding of its performance and future prospects [1].
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet